Skip to main content

Advertisement

Log in

Discolored leg syndrome after vaccination—descriptive epidemiology

  • Original Paper
  • Published:
European Journal of Pediatrics Aims and scope Submit manuscript

Abstract

Discoloration of the leg following vaccination is a relatively unknown entity. We carried out a study of discolored leg syndrome (DLS) during a 10-year consecutive period with the objective of characterizing DLS in infants following vaccination received in the Dutch National Vaccination Program as well as its occurrence and association with different vaccines. Discolored leg syndrome was defined as an even or patchy red, blue or purple discoloration of the leg(s) and/or leg petechiae with or without swelling. All reports of adverse events following immunization that were made to the passive surveillance system between 1994 and 2003 were included—a total of 1162 identified cases. Red, blue, purple discoloration and isolated petechiae were reported in 39, 19, 27 and 14% of these cases, respectively. Of these 1162 cases, 1105 were considered to be related to the vaccination, based on a predefined risk window with symptom onset after vaccination (48 h for discolorations and 2 weeks for petechiae). Of the 1105 cases, about 50% occurred after DTP-IPV+Hib1 vaccinations, and 30% occurred after DTP-IPV+Hib2 vaccinations. Discolored leg syndrome was frequently accompanied by fierce crying (78%). The median time interval between vaccination and the occurrence of DLS was 3.8 ± 46.7 h, and the median duration was short (2 ± 61.7 h). Advancing the vaccination schedule from 3 to 2 months of age caused a small increase in DLS. Discolored leg syndrome manifested mainly after the first and/or second vaccination. In addition to dose, the occurrence of DLS may be slightly age-dependent and self-limiting. The pathophysiology is unknown but may be the result of a vasomotor reaction. Future studies should elucidate the recurrence rate, identify risk factors and assess late outcomes.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

Abbreviations

AEFI:

Adverse event following immunization

aP:

Acellular pertussis vaccine

DLS:

Discolored Leg Syndrome

DTP-IPV:

Diphtheria–whole cell pertussis-tetanus-polio vaccine

HepB:

Hepatitis B vaccine

Hib:

Haemophilus influenzae type b vaccine

MenC:

Meningococcen C vaccine

MMR:

Measles–mumps–rubella vaccine

RIVM:

National Institute for Public Health and the Environment

RVP:

National Vaccination Program

References

  1. Advisory Committee on Immunization Practices (ACIP) (2000) Use of diphtheria toxoid-tetanus toxoid-acellular pertussis vaccine as a five-dose series. Supplemental recommendations of the Advisory Committee on Immunization Practices. MMWR Recomm Rep 49:1–8

    Google Scholar 

  2. Chen RT, Rastogi SC, Mullen JR, Hayes SW, Cochi SL, Donlon JA, Wassilak SG (1994) The Vaccine Adverse Event Reporting System (VAERS). Vaccine 12:542–550

    Article  PubMed  CAS  Google Scholar 

  3. Chuh N, Lee N, Zawar V (2004) The diagnostic criteria of Gianotti–Crosti syndrome: are they applicable to children in India? Pediatr Dermatol 21:542–547

    Article  PubMed  Google Scholar 

  4. Corbett M, Abernethy DA (1999) Harlequin syndrome. J Neurol Neurosurg Psychiatry 66:544

    PubMed  CAS  Google Scholar 

  5. Devillers AC, de Waard-van der Spek FB, Oranje AP (1999) Cutis marmorata telangiectatica congenita: clinical features in 35 cases. Arch Dermatol 135:34–38

    Article  PubMed  CAS  Google Scholar 

  6. Ellenberg SS, Braun MM (2002) Monitoring the safety of vaccines: assessing the risks. Drug Saf 25:145–152

    Article  PubMed  Google Scholar 

  7. Gold MS, Noonan S, Osbourn M, Precepa S, Kempe AE (2003) Local reactions after the fourth dose of acellular pertussis vaccine in South Australia. Med J Aust 179:191–194

    PubMed  Google Scholar 

  8. Halperin SA, Scheifele D, Mills E, Guasparini R, Humphreys G, Barreto L, Smith B (2003) Nature, evolution, and appraisal of adverse events and antibody response associated with the fifth consecutive dose of a five-component acellular pertussis-based combination vaccine. Vaccine 21:2298–2306

    Article  PubMed  CAS  Google Scholar 

  9. Hogun PA (2003) Gianotti–Crosti syndrome. In: Schachner L, Hansen RC (eds) Pediatric dermatology. Mosby, Edinburgh, pp 667–670

    Google Scholar 

  10. Jennette JC, Falk RJ (1997) Small-vessel vasculitis. N Engl J Med 337:1512–1522

    Article  PubMed  CAS  Google Scholar 

  11. Lance JW, Drummond P, Gandevia SC, Morris JG (1988) Harlequin syndrome: the sudden onset of unilateral flushing and sweating. J Neurol Neurosurg Psychiatr 51:635–642

    Article  PubMed  CAS  Google Scholar 

  12. Pehr K, Moroz B (1993) Cutis marmorata telangiectatica congenita: long-term follow-up, review of the literature, and report of a case in conjunction with congenital hypothyroidism. Pediatr Dermatol 10:6–11

    Article  PubMed  CAS  Google Scholar 

  13. Rigante D (2006) Clinical overview of vasculitis syndrome in the pediatric age. Eur Rev Med Pharmacol Sci 10:337–345

    PubMed  CAS  Google Scholar 

  14. Vermeer-de Bondt PE, Labadie J, Rümke HC (1997) Adverse events following immunisation under the National Vaccination Programme of the Netherlands. Reports in 1994. National Institute for Public health and the Environment, Bilthoven, The Netherlands

    Google Scholar 

  15. Verschoor PL, Wilschut JT, de Jonge GA, Kostense PJ (1991) Frequent symptoms after DTPP vaccinations. Arch Dis Child 66:1408–1412

    Article  PubMed  CAS  Google Scholar 

  16. World Health Organization Collaborating Centre for International Drug Monitoring (1991) 14th Annual meeting of participating national centres. World Health Organization, Barcelona

    Google Scholar 

  17. World Health Organization (1991) Surveillance of adverse events following immunization: Field guide for managers of immunization programmes. World Health Organization, Geneva

    Google Scholar 

Download references

Sources of support:

None

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jeanet M. Kemmeren.

Appendix—examples of two case reports

Appendix—examples of two case reports

Case 1

A 3-month-old male infant received his first DTP-IPV and Hib vaccination in both thighs. Four hours later he started to cry inconsolably. Both legs turned blue, with the discoloration ascending from the toes to the pelvic region. His face was ashen pale. He was administered paracetamol suppository and 30 min later the crying stopped. The color of the legs returned to normal. No fever and local reactions were noted. The second vaccinations were uneventful, but the third vaccinations were followed within a few minutes by crying, then by blue discoloration of his feet and red discoloration of his knees within 15 min.

Case 2

An 8-week-old female infant received her first DTP-IPV-Hib in the left leg. After 3.5 h, she woke up screaming. Both legs were discolored evenly fire-engine red, from the groin to the toe; the legs were swollen like “sausages”. After 1 h she calmed down and fell asleep. Four hours later the legs were still swollen and a patchy red. The injection site showed a little lump (<1 cm). The rectal temperature was 37.8°C. The following day she had unblanching spots on both legs with one superficial larger hematoma on one calf.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kemmeren, J.M., Vermeer-de Bondt, P.E. & van der Maas, N.A.T. Discolored leg syndrome after vaccination—descriptive epidemiology. Eur J Pediatr 168, 43–50 (2009). https://doi.org/10.1007/s00431-008-0707-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00431-008-0707-0

Keywords

Navigation